244 related articles for article (PubMed ID: 33019903)
1. The role of aspirin in the prevention of ovarian, endometrial and cervical cancers.
Joharatnam-Hogan N; Cafferty FH; Macnair A; Ring A; Langley RE
Womens Health (Lond); 2020; 16():1745506520961710. PubMed ID: 33019903
[TBL] [Abstract][Full Text] [Related]
2. Influence of aspirin and non-aspirin NSAID use on ovarian and endometrial cancer: Summary of epidemiologic evidence of cancer risk and prognosis.
Verdoodt F; Kjaer SK; Friis S
Maturitas; 2017 Jun; 100():1-7. PubMed ID: 28539172
[TBL] [Abstract][Full Text] [Related]
3. Use of nonsteroidal anti-inflammatory drugs and risk of ovarian and endometrial cancer: the Multiethnic Cohort.
Setiawan VW; Matsuno RK; Lurie G; Wilkens LR; Carney ME; Henderson BE; Kolonel LN; Goodman MT
Cancer Epidemiol Biomarkers Prev; 2012 Sep; 21(9):1441-9. PubMed ID: 22665579
[TBL] [Abstract][Full Text] [Related]
4. Non-steroidal anti-inflammatory drugs and endometrial cancer risk in the VITamins And Lifestyle (VITAL) cohort.
Brasky TM; Moysich KB; Cohn DE; White E
Gynecol Oncol; 2013 Jan; 128(1):113-119. PubMed ID: 23063765
[TBL] [Abstract][Full Text] [Related]
5. Commentary: Does tubal sterilization reduce the risk of gynaecological cancers?
Purdie DM
Int J Epidemiol; 2004 Jun; 33(3):603-4. PubMed ID: 15163643
[No Abstract] [Full Text] [Related]
6. Aspirin and NSAIDs: effects in breast and ovarian cancers.
Crew KD; Neugut AI
Curr Opin Obstet Gynecol; 2006 Feb; 18(1):71-5. PubMed ID: 16493264
[TBL] [Abstract][Full Text] [Related]
7. Primary prevention of gynecologic cancers.
Grimes DA; Economy KE
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):227-35. PubMed ID: 7847546
[TBL] [Abstract][Full Text] [Related]
8. PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer.
Tuyaerts S; Van Nuffel AMT; Naert E; Van Dam PA; Vuylsteke P; De Caluwé A; Aspeslagh S; Dirix P; Lippens L; De Jaeghere E; Amant F; Vandecasteele K; Denys H
BMC Cancer; 2019 May; 19(1):506. PubMed ID: 31138229
[TBL] [Abstract][Full Text] [Related]
9. Analgesic medication use and risk of epithelial ovarian cancer in African American women.
Peres LC; Camacho F; Abbott SE; Alberg AJ; Bandera EV; Barnholtz-Sloan J; Bondy M; Cote ML; Crankshaw S; Funkhouser E; Moorman PG; Peters ES; Schwartz AG; Terry P; Wang F; Schildkraut JM
Br J Cancer; 2016 Mar; 114(7):819-25. PubMed ID: 26908324
[TBL] [Abstract][Full Text] [Related]
10. Hormonal contraception and chemoprevention of female cancers.
Pike MC; Spicer DV
Endocr Relat Cancer; 2000 Jun; 7(2):73-83. PubMed ID: 10903525
[TBL] [Abstract][Full Text] [Related]
11. Prospects for Chemoprevention of Cancers of the Cervix, Endometrium and Ovary: Surrogate Endpoints and Design of Clinical Trials. Conference proceedings. Oxnard, California, February 1-5, 1995.
J Cell Biochem Suppl; 1995; 23():1-250. PubMed ID: 8786651
[No Abstract] [Full Text] [Related]
12. Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement.
Cuzick J; Otto F; Baron JA; Brown PH; Burn J; Greenwald P; Jankowski J; La Vecchia C; Meyskens F; Senn HJ; Thun M
Lancet Oncol; 2009 May; 10(5):501-7. PubMed ID: 19410194
[TBL] [Abstract][Full Text] [Related]
13. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
Petitti DB; Porterfield D
Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340
[TBL] [Abstract][Full Text] [Related]
14. Aspirin Use and Risk of Ovarian Cancer: More Player Pathways for a Common Starting Point?
Mormile R
Cancer Invest; 2019; 37(8):415-416. PubMed ID: 31446811
[No Abstract] [Full Text] [Related]
15. Non-steroidal anti-inflammatory drug use and cervical cancer risk: a case-control study using the Clinical Practice Research Datalink.
Wilson JC; O'Rorke MA; Cooper JA; Murray LJ; Hughes CM; Gormley GJ; Anderson LA
Cancer Epidemiol; 2013 Dec; 37(6):897-904. PubMed ID: 24042024
[TBL] [Abstract][Full Text] [Related]
16. The role of aspirin in preventing colorectal cancer.
Burn J; Sheth H
Br Med Bull; 2016 Sep; 119(1):17-24. PubMed ID: 27543497
[TBL] [Abstract][Full Text] [Related]
17. Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium.
Trabert B; Poole EM; White E; Visvanathan K; Adami HO; Anderson GL; Brasky TM; Brinton LA; Fortner RT; Gaudet M; Hartge P; Hoffman-Bolton J; Jones M; Lacey JV; Larsson SC; Mackenzie GG; Schouten LJ; Sandler DP; O'Brien K; Patel AV; Peters U; Prizment A; Robien K; Setiawan VW; Swerdlow A; van den Brandt PA; Weiderpass E; Wilkens LR; Wolk A; Wentzensen N; Tworoger SS;
J Natl Cancer Inst; 2019 Feb; 111(2):137-145. PubMed ID: 29860330
[TBL] [Abstract][Full Text] [Related]
18. Low-dose aspirin use and the risk of ovarian cancer in Denmark.
Baandrup L; Kjaer SK; Olsen JH; Dehlendorff C; Friis S
Ann Oncol; 2015 Apr; 26(4):787-792. PubMed ID: 25538177
[TBL] [Abstract][Full Text] [Related]
19. [Methodologic and organizational principles of selective screening for cervical, endometrial and ovarian carcinoma].
Zalutskiĭ IV; Vishnevskaia EE; Kurian LM
Vopr Onkol; 2006; 52(1):74-7. PubMed ID: 16715709
[TBL] [Abstract][Full Text] [Related]
20. Cancer prevention and screening in women.
Melnikow J; Nuovo J
Prim Care; 1997 Mar; 24(1):15-26. PubMed ID: 9016727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]